TrialPloS one2012

A pilot randomized, placebo controlled, double blind phase I trial of the novel SIRT1 activator SRT2104 in elderly volunteers.

Vincenzo Libri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.